Anti-CD25 Treatment Depletes Treg Cells and Decreases Disease Severity in Susceptible and Resistant Mice Infected with Paracoccidioides brasiliensis


Autoria(s): Felonato, Maira; Pina, Adriana; Araujo, Eliseu Frank de; Loures, Flavio V.; Bazan, Silvia B.; Feriotti, Claudia; Calich, Vera L. G.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

13/09/2013

13/09/2013

30/11/2012

Resumo

Regulatory T (Treg) cells are fundamental in the control of immunity and excessive tissue pathology. In paracoccidioidomycosis, an endemic mycosis of Latin America, the immunoregulatory mechanisms that control the progressive and regressive forms of this infection are poorly known. Due to its modulatory activity on Treg cells, we investigated the effects of anti-CD25 treatment over the course of pulmonary infection in resistant (A/J) and susceptible (B10.A) mice infected with Paracoccidioides brasiliensis. We verified that the resistant A/J mice developed higher numbers and more potent Treg cells than susceptible B10.A mice. Compared to B10.A cells, the CD4(+)CD25(+)Foxp3(+) Treg cells of A/J mice expressed higher levels of CD25, CTLA4, GITR, Foxp3, LAP and intracellular IL-10 and TGF-beta. In both resistant and susceptible mice, anti-CD25 treatment decreased the CD4(+)CD25(+)Foxp3(+) Treg cell number, impaired indoleamine 2,3-dioxygenase expression and resulted in decreased fungal loads in the lungs, liver and spleen. In A/J mice, anti-CD25 treatment led to an early increase in T cell immunity, demonstrated by the augmented influx of activated CD4(+) and CD8(+) T cells, macrophages and dendritic cells to the lungs. At a later phase, the mild infection was associated with decreased inflammatory reactions and increased Th1/Th2/Th17 cytokine production. In B10.A mice, anti-CD25 treatment did not alter the inflammatory reactions but increased the fungicidal mechanisms and late secretion of Th1/Th2/Th17 cytokines. Importantly, in both mouse strains, the early depletion of CD25(+) cells resulted in less severe tissue pathology and abolished the enhanced mortality observed in susceptible mice. In conclusion, this study is the first to demonstrate that anti-CD25 treatment is beneficial to the progressive and regressive forms of paracoccidioidomycosis, potentially due to the anti-CD25-mediated reduction of Treg cells, as these cells have suppressive effects on the early T cell response in resistant mice and the clearance mechanisms of fungal cells in susceptible mice.

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Pesquisas (CNPq)

Conselho Nacional de Pesquisas (CNPq)

Identificador

PLOS ONE, SAN FRANCISCO, v.7, n.11, p.1-20, 2012

1932-6203

http://www.producao.usp.br/handle/BDPI/33346

10.1371/journal.pone.0051071

http://dx.doi.org/10.1371/journal.pone.0051071

http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0027849&representation=PDF

Idioma(s)

eng

Publicador

Derya Unutmaz

SAN FRANCISCO

Relação

PLoS ONE

Direitos

openAccess

Palavras-Chave #REGULATORY T-CELLS #TRANSCRIPTION FACTOR FOXP3 #PULMONARY PARACOCCIDIOIDOMYCOSIS #FUNGAL-INFECTION #CANDIDA-ALBICANS #IMMUNE-RESPONSES #INDOLEAMINE 2,3-DIOXYGENASE #IMMUNOLOGICAL-TOLERANCE #DENDRITIC CELLS #TGF-BETA #MULTIDISCIPLINARY SCIENCES
Tipo

article

original article

publishedVersion